BrainStorm gets FDA okay for stem cell trial in MS patients
TEL AVIV (Reuters) – BrainStorm Cell Therapeutics Inc has received approval from the U.S. Food and Drug Administration to begin a clinical trial of its experimental stem cell treatment in…
South Korea grappling with smartphone addiction
South Korea has more than 30 million mobile phone users. The devices have become a vital part of everyday life in the country. But owning mobile phones also … source
FDA clears Pluristem radiation treatment for emergency use
HAIFA, Israel (Reuters) – Pluristem Therapeutics Inc, a developer of placenta-based stem cell products, said the U.S. Food and Drug Administration has cleared the emergency use of its therapy to…